News

28 Mar 2018
BB Healthcare announces result of issue Dr Daniel Koller to step back from BB Healthcare

BB Healthcare to benefit from possible Shire takeover

BB Healthcare to benefit from possible Shire takeover London-listed BB Healthcare Trust (BBH) looks likely to be the main investment trust beneficiary of a potential takeover offer for Shire Pharmaceuticals, which may come about after Takeda released a statement suggesting it was evaluating such a move. Shire, which originated in the UK but is now Irish domiciled and […]

28 Mar 2018
Investment Trust Insider on Starwood European Real Estate Finance

Investment Trust Insider on Starwood European Real Estate Finance

Investment Trust Insider on Starwood European Real Estate Finance James Carthew: Starwood loan fund shines after slow start Starwood European Real Estate Finance (SWEF) celebrated its fifth birthday in December. As the name suggests, it invests in debt secured against property in the EU. Its loans typically range between three and seven years with the […]

27 Mar 2018

QuotedData on F&C’s 150th birthday

QuotedData on F&C’s 150th birthday, plus our monthly roundup featured in DIY investor magazine. The granddaddy of the investment trust sector, Foreign & Colonial Investment Trust, is rapidly approaching its 150th birthday. It is a remarkable achievement for a company to remain relevant over such a long period. What, perhaps is even more remarkable is […]

27 Mar 2018

Busy year for Starwood as lending hits record levels

Busy year for Starwood as lending hits record levels – Starwood European Real Estate Finance generated an NAV total return of 7.2 per cent and a share price total return of 7.6 per cent for 2017. Total dividends of 6.5 pence were declared in relation to the year ended 31 December 2017. The manager says that the group […]

27 Mar 2018

Henderson High Income outperforms in 2017

Henderson High Income outperforms in 2017 – Henderson High Income beat its benchmark (80% the All-Share and 20% a gilts index) by 2% in 2017. Unfortunately though, its discount widened and the return to shareholders was 8.7% against 11.4% for the benchmark. the trust expanded by £32m as it absorbed Threadneedle UK Select and also […]

26 Mar 2018

Polar Capital swaps Merck for Lilly

Polar Capital swaps Merck for Lilly – Polar Capital Global Healthcare (PCGH) acquired a large holding, representing ~3% of its NAV, in US pharmaceutical giant Lilly in January, at the same time selling its entire holding  in Merck & Co, according to an analysis by Marten & Co. Lilly appears in 14th position by size as […]

26 Mar 2018

Worldwide Healthcare rejigs portfolio, adds BMS, Vertex stakes

Worldwide Healthcare rejigs portfolio, adds BMS, Vertex stakes OrbiMed-managed Worldwide Healthcare Trust (WWH) has added new large shareholdings in Bristol-Myers Squibb and Vertex to its portfolio, displacing holdings in Intuitive Surgical and Cigna from its top 10, according to the trust’s latest factsheet. The changes follow the addition of a holding in Merck & Co in January, and […]

26 Mar 2018

AEW UK REIT buys Dagenham leisure park

AEW UK REIT buys Dagenham leisure park – AEW UK REIT has acquired the eastern section of London East Leisure Park, Cook Road, Dagenham and an industrial unit let to Plastipak UK Limited on Gresford Industrial Estate, Wrexham for a combined price of GBP22.5m. Dagenham Leisure Park London East Leisure Park is a purpose built leisure […]

23 Mar 2018

Menhaden made some money in 2017

Menhaden made some money in 2017 – Menhaden’s NAV total return for the year ended 31 December 2017 was +7.8% (2016: +1.8%) and the share price total return was +3.2% (2016: -13.8%). The MSCI World Total Return Index (in sterling) increased by 11.8% (2016: +28.2%). By way of additional comparison, the WilderHill New Energy Global Innovation Index […]

23 Mar 2018

BlackRock Emerging Europe offers 100% tender

BlackRock Emerging Europe offers 100% tender – BlackRock Emerging Europe has been out-performing its benchmark, by 5.7% in US dollar terms in the year to 31 January 2018. The NAV increased by 35.5% in US Dollar terms (19.9% in sterling terms) which compared favourably with the benchmark (MSCI Emerging Europe 10-40 Index) return of 29.8% in […]